SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001961863-23-000102
Filing Date
2023-08-30
Accepted
2023-08-30 17:06:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4686
  Complete submission text file 0001961863-23-000102.txt   6369
Mailing Address 65 EAST 55TH STREET, 18TH FLOOR C/O AVISTA CAPITAL PARTNERS NEW YORK NY 10022
Business Address
Dean Thompson (Reporting) CIK: 0001069096 (see all company filings)

State of Incorp.: DE
Type: 144

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Subject) CIK: 0001739426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-38709 | Film No.: 231226022
SIC: 2834 Pharmaceutical Preparations